CongressBuys

Congress trades in Bristol-Myers Squibb Company (BMY)

Healthcare · Drug Manufacturers - General

25 members of Congress have disclosed 96 trades in Bristol-Myers Squibb Company (BMY) since 2014: 42 buys and 54 sales. The most recent was disclosed on Aug 5, 2026. 4 trades were made by members of a committee that oversees Bristol-Myers Squibb Company's industry.

Trades disclosed
96
Members trading
25
Buys / sells
42 / 54
Reported value
$976K–$3.3M

Committee overlaps

Trades by members of a committee that oversees Bristol-Myers Squibb Company's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded BMY

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.